BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1551304)

  • 1. Treatment IND protocol announced for Pneumocystis carinii pneumonia.
    Clin Pharm; 1992 Feb; 11(2):99, 103. PubMed ID: 1551304
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS-related treatment receives IND status.
    J Am Osteopath Assoc; 1992 Jan; 92(1):46. PubMed ID: 1559856
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with atovaquone on a treatment investigational new drug protocol for Pneumocystis carinii pneumonia.
    White A; LaFon S; Rogers M; Andrews E; Brown N
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):280-5. PubMed ID: 7788426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atovaquone for Pneumocystis carinii pneumonia.
    Med Lett Drugs Ther; 1993 Apr; 35(893):28-9. PubMed ID: 8450807
    [No Abstract]   [Full Text] [Related]  

  • 5. Open-label efficacy and safety trial of 42 days of 566C80 for Pneumocystis carinii pneumonia in AIDS patients.
    Dohn MN; Frame PT; Baughman RP; Lafon SW; Smulian AG; Caldwell P; Rogers MD
    J Protozool; 1991; 38(6):220S-221S. PubMed ID: 1818178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS.
    Kazanjian P; Armstrong W; Hossler PA; Lee CH; Huang L; Beard CB; Carter J; Crane L; Duchin J; Burman W; Richardson J; Meshnick SR
    J Infect Dis; 2001 Mar; 183(5):819-22. PubMed ID: 11181161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New AIDS drug available.
    AORN J; 1992 Feb; 55(2):514. PubMed ID: 1536543
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy and prevention of pneumocystis carinii pneumonia].
    Goebel FD; Bogner JR
    Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
    [No Abstract]   [Full Text] [Related]  

  • 9. Atovaquone to be marketed as oral therapy for Pneumocystis carinii pneumonia.
    Clin Pharm; 1993 Mar; 12(3):175-6. PubMed ID: 8491073
    [No Abstract]   [Full Text] [Related]  

  • 10. Atovaquone as prophylaxis for Pneumocystis carinii.
    Vilar FJ; McKendrick MW; Nash C
    Int J STD AIDS; 1996 Jul; 7(4):302. PubMed ID: 8876368
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
    Castro M
    Semin Respir Infect; 1998 Dec; 13(4):296-303. PubMed ID: 9872626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atovaquone: a new oral treatment for pneumocystis.
    Nurse Pract; 1993 Sep; 18(9):22. PubMed ID: 8414230
    [No Abstract]   [Full Text] [Related]  

  • 13. Atovaquone: a new antipneumocystis agent.
    Artymowicz RJ; James VE
    Clin Pharm; 1993 Aug; 12(8):563-70. PubMed ID: 8222520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group.
    Dohn MN; Weinberg WG; Torres RA; Follansbee SE; Caldwell PT; Scott JD; Gathe JC; Haghighat DP; Sampson JH; Spotkov J; Deresinski SC; Meyer RD; Lancaster DJ
    Ann Intern Med; 1994 Aug; 121(3):174-80. PubMed ID: 7880228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis carinii pneumonia treatment in people infected with HIV.
    Bellamy R
    Clin Evid; 2004 Jun; (11):935-50. PubMed ID: 15652046
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current alternatives in the treatment of Pneumocystis carinii pneumonia in patients with AIDS].
    Pastor C; Lumbreras C; Lizasoain M
    Med Clin (Barc); 1994 Oct; 103(12):473-6. PubMed ID: 7996899
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with atovaquone: a new drug for treating Pneumocystis carinii pneumonia.
    Epstein LJ; Mohsenifar Z; Daar ES; Yeh V; Meyer RD
    Am J Med Sci; 1994 Jul; 308(1):5-8. PubMed ID: 8010339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumocystis carinii pneumonia prophylaxis with atovaquone in trimethoprim-sulfamethoxazole-intolerant orthotopic liver transplant patients: a preliminary study.
    Meyers B; Borrego F; Papanicolaou G
    Liver Transpl; 2001 Aug; 7(8):750-1. PubMed ID: 11510024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA authorizes wider use of new oral medication for AIDS.
    Oncology (Williston Park); 1991 Dec; 5(12):59. PubMed ID: 1840024
    [No Abstract]   [Full Text] [Related]  

  • 20. A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome.
    Falloon J; Kovacs J; Hughes W; O'Neill D; Polis M; Davey RT; Rogers M; LaFon S; Feuerstein I; Lancaster D
    N Engl J Med; 1991 Nov; 325(22):1534-8. PubMed ID: 1944437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.